319 related articles for article (PubMed ID: 21799828)
1. Host-adaptation of Francisella tularensis alters the bacterium's surface-carbohydrates to hinder effectors of innate and adaptive immunity.
Zarrella TM; Singh A; Bitsaktsis C; Rahman T; Sahay B; Feustel PJ; Gosselin EJ; Sellati TJ; Hazlett KR
PLoS One; 2011; 6(7):e22335. PubMed ID: 21799828
[TBL] [Abstract][Full Text] [Related]
2. Adaptation of Francisella tularensis to the mammalian environment is governed by cues which can be mimicked in vitro.
Hazlett KR; Caldon SD; McArthur DG; Cirillo KA; Kirimanjeswara GS; Magguilli ML; Malik M; Shah A; Broderick S; Golovliov I; Metzger DW; Rajan K; Sellati TJ; Loegering DJ
Infect Immun; 2008 Oct; 76(10):4479-88. PubMed ID: 18644878
[TBL] [Abstract][Full Text] [Related]
3. Kdo hydrolase is required for Francisella tularensis virulence and evasion of TLR2-mediated innate immunity.
Okan NA; Chalabaev S; Kim TH; Fink A; Ross RA; Kasper DL
mBio; 2013 Feb; 4(1):e00638-12. PubMed ID: 23404403
[TBL] [Abstract][Full Text] [Related]
4. Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia.
Hickey AJ; Hazlett KR; Kirimanjeswara GS; Metzger DW
Vaccine; 2011 Sep; 29(40):6941-7. PubMed ID: 21803089
[TBL] [Abstract][Full Text] [Related]
5. Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS.
Li J; Ryder C; Mandal M; Ahmed F; Azadi P; Snyder DS; Pechous RD; Zahrt T; Inzana TJ
Microbiology (Reading); 2007 Sep; 153(Pt 9):3141-3153. PubMed ID: 17768257
[TBL] [Abstract][Full Text] [Related]
6. Intact O-antigen is critical structure for the exceptional tubular shape of outer membrane vesicles in Francisella tularensis.
Bavlovic J; Pavkova I; Balonova L; Benada O; Stulik J; Klimentova J
Microbiol Res; 2023 Apr; 269():127300. PubMed ID: 36641863
[TBL] [Abstract][Full Text] [Related]
7. Francisella tularensis Schu S4 lipopolysaccharide core sugar and O-antigen mutants are attenuated in a mouse model of tularemia.
Rasmussen JA; Post DM; Gibson BW; Lindemann SR; Apicella MA; Meyerholz DK; Jones BD
Infect Immun; 2014 Apr; 82(4):1523-39. PubMed ID: 24452684
[TBL] [Abstract][Full Text] [Related]
8. Contributions of TolC Orthologs to
Kopping EJ; Doyle CR; Sampath V; Thanassi DG
Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30670554
[No Abstract] [Full Text] [Related]
9. Identification, characterization and immunogenicity of an O-antigen capsular polysaccharide of Francisella tularensis.
Apicella MA; Post DM; Fowler AC; Jones BD; Rasmussen JA; Hunt JR; Imagawa S; Choudhury B; Inzana TJ; Maier TM; Frank DW; Zahrt TC; Chaloner K; Jennings MP; McLendon MK; Gibson BW
PLoS One; 2010 Jul; 5(7):e11060. PubMed ID: 20625403
[TBL] [Abstract][Full Text] [Related]
10. Immunologic consequences of Francisella tularensis live vaccine strain infection: role of the innate immune response in infection and immunity.
Cole LE; Elkins KL; Michalek SM; Qureshi N; Eaton LJ; Rallabhandi P; Cuesta N; Vogel SN
J Immunol; 2006 Jun; 176(11):6888-99. PubMed ID: 16709849
[TBL] [Abstract][Full Text] [Related]
11. Glycoconjugate vaccine using a genetically modified O antigen induces protective antibodies to
Stefanetti G; Okan N; Fink A; Gardner E; Kasper DL
Proc Natl Acad Sci U S A; 2019 Apr; 116(14):7062-7070. PubMed ID: 30872471
[No Abstract] [Full Text] [Related]
12. Role of TLR signaling in Francisella tularensis-LPS-induced, antibody-mediated protection against Francisella tularensis challenge.
Cole LE; Mann BJ; Shirey KA; Richard K; Yang Y; Gearhart PJ; Chesko KL; Viscardi RM; Vogel SN
J Leukoc Biol; 2011 Oct; 90(4):787-97. PubMed ID: 21750122
[TBL] [Abstract][Full Text] [Related]
13. Native outer membrane proteins protect mice against pulmonary challenge with virulent type A Francisella tularensis.
Huntley JF; Conley PG; Rasko DA; Hagman KE; Apicella MA; Norgard MV
Infect Immun; 2008 Aug; 76(8):3664-71. PubMed ID: 18505805
[TBL] [Abstract][Full Text] [Related]
14. Protective B-cell epitopes of Francisella tularensis O-polysaccharide in a mouse model of respiratory tularaemia.
Lu Z; Madico G; Roche MI; Wang Q; Hui JH; Perkins HM; Zaia J; Costello CE; Sharon J
Immunology; 2012 Jul; 136(3):352-60. PubMed ID: 22486311
[TBL] [Abstract][Full Text] [Related]
15.
Benziger PT; Kopping EJ; McLaughlin PA; Thanassi DG
mBio; 2023 Aug; 14(4):e0113623. PubMed ID: 37404047
[No Abstract] [Full Text] [Related]
16. Phosphatidylinositol 3-kinase activation attenuates the TLR2-mediated macrophage proinflammatory cytokine response to Francisella tularensis live vaccine strain.
Medina EA; Morris IR; Berton MT
J Immunol; 2010 Dec; 185(12):7562-72. PubMed ID: 21098227
[TBL] [Abstract][Full Text] [Related]
17. Evidence Suggesting That Francisella tularensis O-Antigen Capsule Contains a Lipid A-Like Molecule That Is Structurally Distinct from the More Abundant Free Lipid A.
Barker JH; Kaufman JW; Apicella MA; Weiss JP
PLoS One; 2016; 11(6):e0157842. PubMed ID: 27326857
[TBL] [Abstract][Full Text] [Related]
18. Outer membrane vesicles displaying engineered glycotopes elicit protective antibodies.
Chen L; Valentine JL; Huang CJ; Endicott CE; Moeller TD; Rasmussen JA; Fletcher JR; Boll JM; Rosenthal JA; Dobruchowska J; Wang Z; Heiss C; Azadi P; Putnam D; Trent MS; Jones BD; DeLisa MP
Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3609-18. PubMed ID: 27274048
[TBL] [Abstract][Full Text] [Related]
19. Repression of inflammasome by Francisella tularensis during early stages of infection.
Dotson RJ; Rabadi SM; Westcott EL; Bradley S; Catlett SV; Banik S; Harton JA; Bakshi CS; Malik M
J Biol Chem; 2013 Aug; 288(33):23844-57. PubMed ID: 23821549
[TBL] [Abstract][Full Text] [Related]
20. Discordant results obtained with Francisella tularensis during in vitro and in vivo immunological studies are attributable to compromised bacterial structural integrity.
Singh A; Rahman T; Malik M; Hickey AJ; Leifer CA; Hazlett KR; Sellati TJ
PLoS One; 2013; 8(3):e58513. PubMed ID: 23554897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
